Motor conduction velocity studies in patients with leprosy reaction treated with thalidomide and other drugs.
D000293:Adolescent; D000328:Adult; D000700:Analgesics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004558:Electric Stimulation; D005260:Female; D006801:Humans; D007918:Leprosy / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009431:Neural Conduction; D009443:Neuritis / Q000188:drug therapy*; D010919:Placebos; D011241:Prednisone / Q000627:therapeutic use*; D013450:Sulfones / Q000627:therapeutic use; D013792:Thalidomide / Q000627:therapeutic use*; D014459:Ulnar Nerve
D000700:Analgesics; D010919:Placebos; D013450:Sulfones; D013792:Thalidomide; D011241:Prednisone